A Pilot Study of Fourier-Domain Optical Coherence Tomography of Retinal Dystrophy Patients

American Journal of Ophthalmology

Volumn 146, Issue 3, 2008, Pages

  Lim, Jennifer I ^a,b   Tan, Ou ^b   Fawzi, Amani A ^b   Hopkins, J Jill ^b,c   Gil Flamer, John H ^b   Huang, David ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c RETINA VITREOUS ASSOCIATES MEDICAL GROUP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOURIER ANALYSIS; HUMAN; MALE; NERVE FIBER; OPTICAL COHERENCE TOMOGRAPHY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA CONE; RETINA DEGENERATION; RETINA DYSTROPHY; RETINA FOVEA; RETINA GANGLION CELL; RETINA MACULA LUTEA; RETINA ROD; RETINITIS PIGMENTOSA; THICKNESS;

EID: 49749107861     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2008.05.018     Document Type: Article

References (19)

1. Huang D., Swanson E.A., Lin C.P., et al. Optical coherence tomography. Science 254 (1991) 1178-1181
2. Fujimoto J.G., Huang D., Hee M.R., et al. Physical properties of optical coherence tomography. In: Schuman J.S., Pulido C.A., and Fujimoto J.G. (Eds). Optical Coherence Tomography of Ocular Diseases. 2nd ed. (2004), SLACK Inc, Thorofare, New Jersey 677-688
3. Huang D., Ou T., Fujimoto J., et al. Optical coherence tomography. In: Huang D., Kaiser P.K., Lowder C.Y., and Traboulsi E.I. (Eds). Retinal Imaging (2006), Mosby Elsevier, Philadelphia, Pennsylvania 47-65
4. Wojtkowski M., Leitgeb R., Kowalczyk A., et al. In vivo human retinal imaging by Fourier-domain optical coherence tomography. J Biomed Opt 7 (2002) 457-463
5. Choma M.A., Sarunic M.V., Yang C., and Izatt J.A. Sensitivity advantage of swept source and Fourier-domain optical coherence tomography. Opt Express 11 (2003) 2183-2189
6. Leitgeb R., Hitzenberger C.K., and Fercher A.F. Performance of fourier domain vs. time domain optical coherence tomography. Opt Express 11 (2003) 889-894
7. Wojtkowski M., Srinivasan V., Fujimoto J.G., et al. Three-dimensional retinal imaging with high-speed ultra-high-resolution optical coherence tomography. Ophthalmology 112 (2005) 1734-1746
8. Witkin A.J., Ko T.H., Fujimoto J.G., et al. Ultra-high resolution optical coherence tomography assessment of photoreceptors in retinitis pigmentosa and related diseases. Am J Ophthalmol 142 (2006) 945-952
9. Drexler W., Morgner U., Ghanta R.K., et al. Ultra-high-resolution ophthalmic optical coherence tomography. Nat Med 7 (2001) 502-507
10. Drexler W., Sattmann H., Hermann B., et al. Enhanced visualization of macular pathology with the use of ultra-high-resolution optical coherence tomography. Arch Ophthalmol 121 (2003) 695-706
11. Srinivasan V.J., Wojtkowski M., Witkin A.J., et al. High-definition and 3-dimensional imaging of macular pathologies with high-speed ultra-high-resolution optical coherence tomography. Ophthalmology 113 (2006) 2054.e1-2054.e14
12. Ko T.H., Fujimoto J.G., Schuman J.S., et al. Comparison of ultra-high- and standard-resolution optical coherence tomography for imaging macular pathology. Ophthalmology 111 (2004) 2033-2043
13. Ergun E., Hermann B., Wirtitsch M., et al. Assessment of central visual function in Stargardt disease/fundus flavimaculatus with ultrahigh-resolution optical coherence tomography. Invest Ophthalmol Vis Sci 46 (2005) 310-316
14. Huber R., Adler D.C., and Fujimoto J.G. Buffered Fourier-domain mode locking: Unidirectional swept laser sources for optical coherence tomography imaging at 370,000 lines/s. Opt Lett 31 (2006) 2975-2977
15. Pagon R.A. Retinitis pigmentosa. Surv Ophthalmol 33 (1988) 137-177
16. Milam A.H., Li Z.Y., and Fariss R.N. Histopathology of the human retina in retinitis pigmentosa. Prog Retin Eye Res 17 (1998) 175-205
17. Tucker G.S., and Jacobson S.G. Morphological findings in retinits pigmentosa with early diffuse rod dysfunction. Retina 8 (1988) 30-41
18. Heckenlively J.R. Retinitis pigmentosa (1988), J.B. Lippincott Co, Philadelphia, Pennsylvania 55-60
19. The Advanced Glaucoma Intervention Study Investigators. The Advanced Glaucoma Intervention Study (AGIS): 1. Study design and methods, and baseline characteristics of study patients. Control Clin Trials 15 (1994) 299-325